Akebia Therapeutics Inc Stock Ownership - Who owns Akebia Therapeutics?

Insider buying vs selling

Have Akebia Therapeutics Inc insiders been buying or selling?
Nicole R. HadasSVP Chief Legal Officer2023-05-2563,186$1.22
Michel DahanSVP Chief Operating Officer2023-05-2595,478$1.22
Steven Keith BurkeSVP Chief Medical Officer2023-05-1663,567$1.07
David A. SpellmanSVP CFO and Treasurer2023-05-1663,567$1.07
John P. ButlerCEO and President2023-03-016,370$0.88
John P. ButlerCEO and President2023-03-0147,239$0.88
John P. ButlerCEO and President2023-03-0138,259$0.88
Michel DahanSVP Chief Operating Officer2023-03-011,878$0.88
Michel DahanSVP Chief Operating Officer2023-03-0110,476$0.88
Steven Keith BurkeSVP Chief Medical Officer2023-03-011,110$0.88

1 of 3

AKBA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKBA insiders and whales buy or sell their stock.

AKBA Shareholders

What type of owners hold Akebia Therapeutics Inc stock?
Alerce Investment Management LP8.72%16,205,119$17.83MInstitution
Vanguard Group Inc6.73%12,510,904$13.76MInstitution
Acadian Asset Management LLC4.02%7,483,053$8.23MInstitution
Muneer A. Satter2.71%5,039,602$5.54MInsider
Novartis Bioventures Ltd1.83%3,405,764$3.75MInsider
Blackrock Inc1.45%2,703,523$2.97MInstitution
John P. Butler1.33%2,466,372$2.71MInsider
Renaissance Technologies LLC1.26%2,338,500$2.57MInstitution
Geode Capital Management LLC0.90%1,682,498$1.85MInstitution
Holdings A. Novo0.82%1,516,387$1.67MInsider

1 of 3

AKBA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKBA27.96%8.80%Net SellingNet Selling
EYPT13.73%86.27%Net SellingNet Selling
ALT40.85%59.15%Net SellingNet Buying

Akebia Therapeutics Stock Ownership FAQ

Who owns Akebia Therapeutics?

Akebia Therapeutics (NASDAQ: AKBA) is owned by 27.96% institutional shareholders, 8.80% Akebia Therapeutics insiders, and 63.24% retail investors. Muneer A. Satter is the largest individual Akebia Therapeutics shareholder, owning 5.04M shares representing 2.71% of the company. Muneer A. Satter's Akebia Therapeutics shares are currently valued at $5.64M.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.